-- Amazon (AMZN) said Tuesday that launched a GLP-1 management program through Amazon One Medical.
The company said the program is designed to integrate GLP-1 management into primary care, pharmacy services through Amazon Pharmacy, and virtual care options. Amazon Pharmacy offers GLP-1 treatments such as Wegovy and Foundayo oral GLP-1 pills, Amazon added.
AMZN shares were up 1.8% in early trading Tuesday.
Price: $252.72, Change: $+4.44, Percent Change: +1.79%